Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
-
Field
-
molecular imaging research program. This platform will support translational studies mainly in oncology, through quantitative multimodal imaging (PET-CT, SPECT-CT, optical imaging, autoradiography
-
omics data (genomics, transcriptomics, proteomics, metabolomics) and integrative multi-level analysis Experience in medical image processing and analysis (MRI, PET, digital histology, microscopy
-
of myocardial fibrosis using 68Ga-FAPI-04 PET/CT (Protein Positron Emission Tomography associated with Computed Tomography using Gallium-68-labeled Fibroblast Activation Inhibitor), integrating multimodal imaging
-
(IVIS). Peptide radiolabeling will then be carried out by our radiochemistry team. The candidate will conduct biodistribution and dosimetry studies using in vivo longitudinal imaging (SPECT-CT or PET-CT
-
the data repository and computer servers. Runs existing PET/MR brain image processing pipelines on the computer servers, produces the results, and communicates with the group members. Writes computer codes
-
-of-the-art brain imaging facilities (two research-dedicated MRI scanners: 1.5T and 3T, hybrid PET-3T MRI, MEG-EEG). The vibrant research community at CRNL and nearby neuroscience institutes (ISC, SBRI, see
-
funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Setup and operation of a PET-SCAN prototype using MCPs as sensors - Design a vacuum
-
dogs with metastatic osteosarcoma 1. Assist with PET-CT and SPECT-CT imaging, image segmentation, and data analysis before and after treatment with RPT. Research fellow will be expected
-
vivarium, a cell culture room, and state-of-the-art flow cytometry, microscopy, and next-generation sequencing equipment. Furthermore, our cutting-edge imaging facilities (including PET, MR, IVIS, and CT
-
Research Scholarship of Post-Doctoral Research for the scientific area of Chemistry - IST/2025/BL103
for in vivo recognition of FAP. The biodistribution of the radiolabeled miniproteins will be evaluated in animal models. PET/SPECT imaging will be performed to assess their pharmacokinetics and to support